Cethromycin: A Promising New Ketolide Antibiotic for Respiratory Infections
Author:
Publisher
Wiley
Subject
Pharmacology (medical)
Reference64 articles.
1. The cost of treating community-acquired pneumonia
2. Prevalence and Antibacterial Susceptibility of mef (A)-Positive Macrolide-Resistant Streptococcus pneumoniae over 4 Years (2000 to 2004) of the PROTEKT US Study
3. Regional trends in β-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001–2004
4. Antimicrobial Resistance amongStreptococcus pneumoniaein the United States: Have We Begun to Turn the Corner on Resistance to Certain Antimicrobial Classes?
5. The FDA and the Case of Ketek
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nafithromycin (MIQNAF®): ultramodern lactone ketolide designed to treat community acquired bacterial pneumonia (CABP);Medicinal Chemistry Research;2024-07-23
2. Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement;Molecular Diversity;2024-03-30
3. Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens;Antibiotics;2023-12-11
4. The antimicrobial activity of cethromycin against Staphylococcus aureus and compared with erythromycin and telithromycin;BMC Microbiology;2023-04-20
5. Carbohydrate-based drugs launched during 2000−2021;Acta Pharmaceutica Sinica B;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3